Delivery Order SPE2DB22D3004-SPE2DB24FPJ45
Award Date 2/16/24
Potential Completion Date 2/20/24
Potential Value $1.3K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,714,600 units of Ondansetron HCl 8 mg tablets. The contract has a completion date of February 21, 2024 and a potential value of $1,287.79. This delivery order is part of a larger Indefinite Delivery Contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,563,728,753 units of Ondansetron ODT 8 mg tablets. The $3,297.64 contract has a completion date of February 22, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order is issued under an indefinite delivery contract (IDC) valued up...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of Ondansetron HCL 8 mg tablets in 30-count packages. The contract has a potential value of $29,504.32 and a completion date of February 5, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor supplying pharmaceutical products and medical supplies to DLA Troop Support...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of Ondansetron HCL 8 mg tablets. The $2,780.75 contract has a completion date of February 2, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen with a potential...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,564,108,585 units of Ondansetron HCL 4 mg tablets. The contract has a ceiling value of $20,428.34 and a completion date of March 29, 2024. AmerisourceBergen Drug Corp is also the prime contractor on an indefinite delivery contract (IDC) awarded by DLA, with a potential...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,564,261 units of 8 mg ondansetron hydrochloride tablets in 30-count packaging. The $1,639.24 delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,564,125,413 units of the prescription drug Ondansetron ODT 8mg Tablet. The contract, valued at $1,189.99, has an ultimate completion date of April 1, 2024. As the prime contractor, Amerisourcebergen Drug Corp will deliver these pharmaceutical products from its Corporate Office in Conshohocken, Pennsylvania to support...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of 4,564,029,396 units of Ondansetron HCl 4 mg tablets in 500-count bottles. The $64,926.98 contract has a performance period ending on March 21, 2024. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, which serves as the...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,828,537 tablets of ondansetron hydrochloride 8 mg for a potential value of $14,611.72. The contract has a completion date of March 4, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation. This delivery order contract is part of a larger indefinite delivery contract (IDC)...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply Ondansetron HCL 4 mg tablets. The $1,667.12 contract has a completion date of February 6, 2024. Amerisourcebergen Drug Corp is the prime contractor and there are no set-aside designations indicated. This delivery order is issued under a larger indefinite delivery contract (IDC) with a potential...